Applied Molecular Transport

Acerta Pharma, an affiliate of AstraZeneca, is at the forefront of advancing care in haematology by developing innovative investigational agents aimed at directly targeting cancer cells and harnessing the immune system to combat cancer. The company focuses on addressing blood cancers with significant unmet needs by enriching its pipeline with first-in-class and best-in-class medicines. In collaboration with AstraZeneca, Acerta Pharma employs cutting-edge drug discovery techniques to create transformational therapies for patients with hematological malignancies. With a state-of-the-art research and development center in the Netherlands, the company fosters partnerships with academic and commercial entities to enhance its oncology portfolio. Generated from the website

KalVista Pharmaceuticals is a biopharmaceutical company based in Newark, CA, dedicated to the discovery, development, and commercialization of small molecule protease inhibitors for the treatment of various diseases. With a focus on advancing innovative therapies, KalVista Pharmaceuticals conducts research and clinical trials to address unmet medical needs and improve patient outcomes in the healthcare industry. Generated from their business information

K2X Technology Life Science, Inc., based in Los Altos Hills, CA, is a FinTech company in Silicon Valley that offers global investors a unique opportunity to invest in a diversified portfolio of thoroughly vetted startups. Managed by experienced angel investors, K2X provides a safer, higher-return, and non-correlated investment option, targeting the top 10 startups in the market. With a focus on innovation and global reach, K2X aims to create an ETF-like vehicle for investing in angel-stage startups, providing liquidity and diversity for investors seeking a novel approach to startup investments. Their double-vetted investment strategy ensures a secure and agnostic investment experience, regardless of market or geography.Generated from the website